Comprehensive Study Notes on Psychotropic, Antiepileptic, and Antiparkinsonian Pharmacology
Atypical Antipsychotics and Extrapyramidal Symptoms (EPS)
Atypical Antipsychotic Agents and Clinical Uses:
Olanzapine and Ziprasidone: Used in the management of bipolar disorders to control manic states and hyperexcitability; administered parenterally for the acute management of agitation.
Quetiapine: Approved for short-term management of acute manic episodes associated with bipolar disorder; suppresses hyperexcitability and reduces behavioral outbursts.
Risperidone (Risperdal): Frequently prescribed for children and adolescents to treat irritability and aggression associated with autistic disorders, including aggressive meltdowns and temper tantrums.
Metabolic Adverse Effects of Risperidone: Carries an elevated risk of rapid weight gain, diabetes mellitus (hyperglycemia), and dyslipidemia (elevated serum cholesterol).
Extrapyramidal Motor Symptoms (EPS) Manifestations:
Pseudoparkinsonism: Presents with a stooped, slouched posture, bradykinesia (markedly slowed physical movements), resting tremors (specifically classic pill-rolling tremors involving rhythmic motion of the thumb against the index or middle finger), and a shuffling gait consisting of short steps caused by joint rigidity and reduced range of motion in the knees and legs.
Akathisia: Manifests as severe motor restlessness, difficulty standing still, constant rocking back and forth, feet in continuous motion, and compulsive pacing.
Acute Dystonia: Characterized by facial grimacing, involuntary upward eye movement (oculogyric crisis), muscle spasms of the tongue, face, and neck, severe back spasms causing forward arching and protrusion of the trunk, and dangerous laryngeal spasms.
Tardive Dyskinesia: Involuntary movements of the extremities and trunk accompanied by facial dyskinesia, including tongue protrusion and rolling, lip smacking, sucking movements of the lips, and repetitive chewing motions.
Pharmacologic Management of EPS:
Anticholinergic Agents: Alleviate pseudoparkinsonism, acute dystonia, and akathisia by counteracting acetylcholine excess.
Acute Dystonic Spasms: Managed immediately with anticholinergic or antiparkinsonian agents such as benztropine (Cogentine) or diphenhydramine (Benadryl), or with benzodiazepines such as lorazepam (Ativan).
Akathisia: Best treated using a beta-blocker such as propranolol or a benzodiazepine such as lorazepam (Ativan).
Tardive Dyskinesia: Managed with benzodiazepines, calcium channel blockers, or beta-blockers.
Neuroleptic Malignant Syndrome (NMS)
Pathophysiology and Prognosis: A rare, life-threatening adverse reaction to antipsychotic pharmacotherapy precipitated by acute, severe central dopamine depletion.
Clinical Presentation:
Marked muscle rigidity.
Sudden, severe high fever (hyperpyrexia).
Altered mental status and progression to coma.
Autonomic instability, including blood pressure fluctuations, tachycardia, and cardiac dysrhythmias.
Systemic complications, including seizures, acute renal failure, and respiratory failure.
Emergency Nursing and Medical Interventions:
Immediately discontinue the causative antipsychotic medication.
Dantrolene: Direct-acting skeletal muscle relaxant administered to alleviate severe muscular rigidity and reduce hyperthermia.
Bromocriptine: Direct dopamine receptor agonist administered to stimulate central dopamine receptors, reverse central nervous system toxicity, and restore dopaminergic equilibrium.
Mood Stabilizers and Lithium Therapy
Overview of Mood Stabilizers: First-line agents for bipolar affective disorder include lithium, carbamazepine, valproic acid, and lamotrigine (Lamictal).
Mechanism of Action of Lithium:
Historically the first agent utilized for bipolar disorder.
Downregulates excitatory neurotransmission (dopamine and glutamate) while upregulating inhibitory neurotransmission ().
Exerts a calming effect to control manic hyperexcitability, flight of ideas, and motor hyperactivity.
Adverse Effects vs. Toxic Manifestations:
Expected Side Effects: Dry mouth, polydipsia (excessive thirst), polyuria (increased urination, reflecting the physiological principle that water follows sodium), weight gain, abdominal bloating, pedal edema of the hands and ankles, metallic taste, mild memory impairment, and transient confusion.
Signs of Lithium Toxicity: Early manifestations include persistent nausea, vomiting, diarrhea, and generalized muscle weakness. Advanced toxicity presents with severe hand tremors, ataxia, slurred speech, profound drowsiness, marked confusion, seizures, and comatose state.
Therapeutic Range and Toxicity Threshold:
Therapeutic serum concentration: .
Toxicity threshold: Concentrations of and above are considered toxic.
Nursing Considerations for Lithium Administration:
Blood Level Monitoring: Maintain regular daily serum level monitoring to confirm steady-state concentrations within the therapeutic window.
Hydration: Maintain adequate fluid intake of per day as clinically indicated.
Sodium Homeostasis: Maintain consistent dietary sodium intake; sodium restriction causes renal tubules to retain and reabsorb lithium, precipitating lithium toxicity.
Clinical Onset: Therapeutic effects require to manifest, reaching initial peak efficacy around . Acute manic symptoms necessitate temporary concurrent coverage with an antipsychotic agent until lithium reaches therapeutic efficacy.
Gastrointestinal Protection: Administer doses with meals to prevent mucosal distress and gastric irritation.
Supportive Measures for Xerostomia: Provide small frequent meals, sugarless lozenges, sips of fluid, and ice chips to stimulate salivary flow; standard oral hygiene with toothbrush and paste is sufficient without requiring commercial mouthwashes.
Safety and Emotional Support: Implement injury-prevention protocols (side rails, ambulation assistance) and provide emotional support to assist with therapy adherence.
Overview and Classification of Seizure Disorders
Definitions:
Epilepsy: A collection of clinical syndromes characterized by recurrent unprovoked seizures resulting from sudden, excessive electrical energy discharges from cerebral neurons.
Convulsions: The physical, violent jerking and stiffening of skeletal muscles (tonic-clonic muscular reaction) triggered by central neuronal electrical discharges.
Anticonvulsant Mechanism: Antiseizure agents act analogously to circuit breakers, altering neuronal ion channels or neurotransmitter concentrations to terminate, suppress, or prevent electrical surges.
Partial (Focal) Seizures (Involving One Cerebral Hemisphere):
Simple Partial Seizures: Consciousness remains intact and the patient stays awake.
Complex Partial Seizures: Impairment of consciousness occurs; the patient becomes confused or unconscious, experiencing sensory-motor, emotional, and psychic disturbances, frequently followed by amnesia regarding the event.
Jacksonian Seizures: Focal motor seizures initiating in one localized anatomical region (e.g., twitching of an isolated finger or foot) that spread progressively through the limb and may evolve secondarily into a generalized tonic-clonic seizure.
Generalized Seizures (Involving Both Cerebral Hemispheres):
Tonic-Clonic Seizures (Grand Mal): Characterized by dramatic tonic contractions (severe muscle rigidity and stiffening) followed by clonic contractions (rhythmic muscle jerking), accompanied by immediate loss of consciousness and followed by a distinct postictal period marked by profound exhaustion and confusion.
Absence Seizures (Petit Mal): Brief, abrupt episodes lasting featuring sudden loss of awareness, behavioral arrest, and blank staring spells (resembling daydreams) without an associated postictal recovery period.
Myoclonic Seizures: Short, sporadic periods of sudden muscle contractions or jerks that can persist over several minutes, often presenting as secondary seizures.
Febrile Seizures: Generalized tonic-clonic seizures provoked by rapid, high fever spikes ( and above), occurring primarily in pediatric populations due to immature central thermoregulation.
Status Epilepticus: A medical emergency defined as continuous, uninterrupted seizure activity lasting or longer, or rapid recurrent seizures occurring without intervening recovery of consciousness, carrying an extreme risk of irreversible brain damage.
Anticonvulsant and Antiepileptic Pharmacology
Principles of Antiepileptic Therapy:
Initiate therapy using monotherapy with a single drug, titrating the dose gradually until seizure control is achieved or intolerable adverse reactions occur.
If the initial agent fails, substitute an alternative single agent as monotherapy prior to attempting combination therapy.
Used for lifelong management of chronic epilepsy, short-term prevention following traumatic brain injury or cerebral edema, and emergent termination of status epilepticus.
Anticonvulsant Drug Classes:
Hydantoins (Phenytoin / Dilantin): Stabilize neuronal membranes throughout the central nervous system by directly modulating ionic channels in cell membranes, decreasing hyperexcitability and suppressing repetitive discharges.
Barbiturates (Phenobarbital): Enhance receptor activation to depress synaptic conduction across the cerebral cortex and brainstem; causes pronounced central nervous system sedation and drowsiness; prescribed for generalized tonic-clonic seizures.
Benzodiazepines (Diazepam, Lorazepam, Clonazepam): Potentiate inhibitory effects of .
Diazepam (Valium) and Lorazepam (Ativan): First-line emergency rescue agents for acute status epilepticus and benign febrile seizures; not indicated for long-term chronic control due to profound sedation and respiratory depression.
Clonazepam: Specifically utilized for petit mal (absence) and myoclonic seizures.
Succinimides (Ethosuximide, Methosuximide): Enhance neurotransmission. Ethosuximide is the gold standard drug of choice for petit mal (absence) seizures due to superior efficacy and a favorable adverse-effect profile. Methosuximide is reserved for refractory cases.
Valproic Acid (Valproate): Drug of choice for myoclonic seizures; decreases neuronal excitability by suppressing calcium influx, blocking voltage-gated sodium channels, and enhancing activity.
Other Antiseizure Agents: Carbamazepine, gabapentin, and lamotrigine are used for partial seizures. Carbamazepine is additionally indicated for neuropathic pain syndromes, specifically trigeminal neuralgia.
Nursing Considerations for Anticonvulsant Therapy:
Administer oral doses with food to minimize gastrointestinal upset.
Monitor complete blood count () to detect drug-induced bone marrow suppression, watching specifically for:
Leukopenia: Abnormally low white blood cell count.
Thrombocytopenia: Abnormally low platelet (thrombocyte) count.
Aplastic Anemia: Rare failure of bone marrow to produce sufficient quantities of all blood cell types.
Monitor therapeutic serum drug concentrations to avoid toxicity.
Instruct clients to wear a MedicAlert identification bracelet.
Ensure interprofessional communication during nursing handoffs, endorsing seizure history, drug regimens, and safety precautions.
Antiparkinsonian Pharmacotherapy: Pathophysiology and Mechanisms
Pathophysiology of Parkinson's Disease:
A chronic neurodegenerative central nervous system disorder occurring primarily in older adults ( of age and older).
Caused by the progressive degeneration of dopaminergic neurons in the substantia nigra of the midbrain.
Results in severe depletion of inhibitory dopamine, leading to unchecked, excessive cholinergic (acetylcholine) excitation in the extrapyramidal motor system.
Acetylcholine serves as an excitatory accelerator of muscle activity; dopamine acts as the inhibitory regulator required for smooth, controlled voluntary movement.
Therapeutic Strategy and Palliative Goal:
Pharmacotherapy aims to re-establish neurotransmitter equilibrium using the principle of "IDDA": Increase Dopamine, Decrease Acetylcholine.
Medications do not cure the underlying neurodegeneration; treatment is palliative, controlling motor symptoms to preserve functional mobility.
Four Cardinal Features of Parkinson's Disease:
Muscle Rigidity: Muscular stiffness and joint inflexibility, classically presenting as cogwheel rigidity (rachet-like, jerky resistance felt during passive limb movement).
Akinesia or Bradykinesia: Total loss (akinesia) or marked slowness (bradykinesia) of voluntary motor initiation and execution.
Resting Tremor: Pill-rolling tremors of the hands occurring at rest.
Disturbances of Posture and Balance: Postural instability, stooped posture, and a shuffling gait with trembling extremities, creating high fall risks.
Anticholinergic and Dopaminergic Agents for Parkinson's Disease
Anticholinergic Agents (Parasympatholytics):
Specific Agents: Diphenhydramine (Benadryl), benztropine (Cogentine), beperidone (Kenetone), and trihexifenidyl (Arthane).
Mechanism of Action: Inhibit acetylcholine action at parasympathetic muscarinic receptors to dampen excess cholinergic excitation, thereby controlling tremors and rigidity; indicated in early Parkinson's disease and for drug-induced extrapyramidal symptoms.
Nursing Considerations:
Thermoregulation: Anticholinergic agents reduce sweating; exercise caution in hot weather or warm environments to prevent severe hyperthermia and heat stroke.
Urinary Retention: Instruct patients to void immediately before taking the drug, as parasympatholytic effects promote urinary retention.
Geriatric Vulnerability: Elderly patients exhibit heightened sensitivity, with increased risk for drug-induced delirium, confusion, and toxicity.
Xerostomia: Provide ice chips, water sips, and sugarless hard candies or gum to stimulate salivation.
Constipation: Increase dietary intake of fluids and fiber.
Dopaminergic Agents:
Levodopa: Metabolic precursor of dopamine capable of crossing the blood-brain barrier, functioning as the substrate for central dopamine synthesis.
Carbidopa-Levodopa Combination:
When levodopa is administered alone, approximately is metabolized peripherally in the gastrointestinal tract and blood vessels, precipitating severe nausea, vomiting, and cardiac palpitations, leaving only to reach the brain.
Carbidopa acts as an enzymatic shield that prevents peripheral breakdown of levodopa, enabling a substantially reduced levodopa dose while lowering gastrointestinal and cardiovascular side effects.
Amantadine: An antiviral medication exhibiting dopaminergic activity by stimulating the endogenous release of dopamine from neuronal storage sites.
Bromocriptine: A direct dopamine receptor agonist that stimulates post-synaptic dopaminergic receptors controlling motor activity.
Selegiline: A selective type B monoamine oxidase inhibitor ( inhibitor) that inhibits the central enzymatic degradation of dopamine.
Critical Administration Rules and Drug Interactions:
Tapering Requirement: Never discontinue dopaminergic medications abruptly; dosage must be tapered down gradually to prevent triggering an acute parkinsonian crisis (marked clinical deterioration).
Interaction: Concurrent administration of dopaminergic agents with monoamine oxidase inhibitors () risks massive catecholamine accumulation, precipitating a life-threatening hypertensive crisis.
Pyridoxine (Vitamin ) Interaction: Vitamin (pyridoxine) acts as an essential cofactor that accelerates the peripheral degradation of levodopa, abolishing its therapeutic effect; concurrent intake must be avoided.
Antagonistic Interactions: Phenytoin and dopamine receptor antagonists directly diminish the therapeutic efficacy of dopaminergic agents.